Solid Biosciences
SLDB
74 hedge funds and large institutions have $157M invested in Solid Biosciences in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 23 closing their positions.
106% more call options, than puts
Call options by funds: $6.18M | Put options by funds: $3M
67% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 15
4% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 23
1% less funds holding
Funds holding: 75 → 74 (-1)
1.33% less ownership
Funds ownership: 4.55% → 3.22% (-1.3%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
76% less capital invested
Capital invested by funds: $648M → $157M (-$491M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
+$11.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$8.69M |
| 3 |
Barclays
London,
United Kingdom
|
+$7.15M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.55M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$105M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$35.8M |
| 3 |
JP Morgan Chase
New York
|
-$27.5M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$23.2M |
| 5 |
Jennison Associates
New York
|
-$21.1M |
SLDB Hedge Fund Activity: Q1 2019 in Review
74 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2019, worth a combined $157M — down 76% from $648M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of SLDB and 22 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 25 added.
The largest buyer was Artal Group, adding an estimated $11.7M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $105M sold.
- 74 institutional investors held Solid Biosciences (SLDB) as of Q1 2019, down from 75 in Q4 2018.
- Funds reported $157M of Solid Biosciences stock for Q1 2019, down 76% quarter-over-quarter.
- 22 funds opened new Solid Biosciences positions in Q1 2019 and 23 closed out, a net change of -1 holder.
- The largest Solid Biosciences buyer in Q1 2019 was Artal Group, an estimated $11.7M added.
- The largest Solid Biosciences seller in Q1 2019 was Perceptive Advisors, an estimated $105M sold.
Based on aggregated 13F filings for Q1 2019.